0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary | 
Matthew R. Cooperberg, MD, MPH
JAMA Intern Med. 2013;173(12):1143-1144. doi:10.1001/jamainternmed.2013.6755.

Original Investigation | 
Gregg H. Goldin, MD; Nathan C. Sheets, MD; Anne-Marie Meyer, PhD; et al.
JAMA Intern Med. 2013;173(12):1136-1143. doi:10.1001/jamainternmed.2013.1020.
Includes: Supplemental Content

Viewpoint | 
Susan Desmond-Hellmann, MD, MPH
JAMA Intern Med. 2013;173(12):1051-1052. doi:10.1001/jamainternmed.2013.826.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
JAMA Patient Page  | 
Proton Beam Therapy for Prostate Cancer
Deborah Tolmach Sugerman, MSW; Edward H. Livingston, MD
JAMA
Lab Reports  | 
Bar Code Technology Enables Cancer Cell Protein Analysis
Tracy Hampton, PhD
JAMA
Original Investigation  | 
Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012
Nicholas S. Downing, AB; Jenerius A. Aminawung, MD, MPH; Nilay D. Shah, PhD; et al.
JAMA
Viewpoint  | 
The Accelerated Approval of Oncologic Drugs:  Lessons From Ponatinib
Vinay Prasad, MD; Sham Mailankody, MB, BS